415 related articles for article (PubMed ID: 20692741)
1. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
Kumar D; Maruthi Kumar N; Chang KH; Shah K
Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel indolyl-1,2,4-triazoles as potent and selective anticancer agents.
Kumar D; Narayanam MK; Chang KH; Shah K
Chem Biol Drug Des; 2011 Mar; 77(3):182-8. PubMed ID: 21251232
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles.
Kumar D; Kumar NM; Chang KH; Gupta R; Shah K
Bioorg Med Chem Lett; 2011 Oct; 21(19):5897-900. PubMed ID: 21873049
[TBL] [Abstract][Full Text] [Related]
4. A series of 2-arylamino-5-(indolyl)-1,3,4-thiadiazoles as potent cytotoxic agents.
Kumar D; Kumar NM; Noel B; Shah K
Eur J Med Chem; 2012 Sep; 55():432-8. PubMed ID: 22818039
[TBL] [Abstract][Full Text] [Related]
5. An expeditious synthesis and anticancer activity of novel 4-(3'-indolyl)oxazoles.
Kumar D; Kumar NM; Sundaree S; Johnson EO; Shah K
Eur J Med Chem; 2010 Mar; 45(3):1244-9. PubMed ID: 20047778
[TBL] [Abstract][Full Text] [Related]
6. Novel bis(indolyl)hydrazide-hydrazones as potent cytotoxic agents.
Kumar D; Maruthi Kumar N; Ghosh S; Shah K
Bioorg Med Chem Lett; 2012 Jan; 22(1):212-5. PubMed ID: 22123320
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiproliferative activity of some 5-substituted 2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles.
Matysiak J; Nasulewicz A; Pełczyńska M; Switalska M; Jaroszewicz I; Opolski A
Eur J Med Chem; 2006 Apr; 41(4):475-82. PubMed ID: 16517026
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer evaluation of novel 2-cyclopropylimidazo[2,1-b][1,3,4]-thiadiazole derivatives.
Noolvi MN; Patel HM; Singh N; Gadad AK; Cameotra SS; Badiger A
Eur J Med Chem; 2011 Sep; 46(9):4411-8. PubMed ID: 21820217
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative activity of N-substituted 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles.
Matysiak J; Opolski A
Bioorg Med Chem; 2006 Jul; 14(13):4483-9. PubMed ID: 16517170
[TBL] [Abstract][Full Text] [Related]
10. One-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazoles.
Kumar D; Vaddula BR; Chang KH; Shah K
Bioorg Med Chem Lett; 2011 Apr; 21(8):2320-3. PubMed ID: 21429743
[TBL] [Abstract][Full Text] [Related]
11. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.
Kumar D; Sundaree S; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 Aug; 19(15):4492-4. PubMed ID: 19559607
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel 2-(quinolin-8-yloxy) acetohydrazones and their cyclized products (1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives).
Hayat F; Salahuddin A; Zargan J; Azam A
Eur J Med Chem; 2010 Dec; 45(12):6127-34. PubMed ID: 20961670
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 5-formyl-6-arylimidazo(2,1-b)-1,3,4-thiadiazole-2-N-(dimethylaminomethi no) sulfonamides as antitumor agents.
Gadad AK; Karki SS; Rajurkar VG; Bhongade BA
Arzneimittelforschung; 1999 Oct; 49(10):858-63. PubMed ID: 10554665
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents.
Karki SS; Panjamurthy K; Kumar S; Nambiar M; Ramareddy SA; Chiruvella KK; Raghavan SC
Eur J Med Chem; 2011 Jun; 46(6):2109-16. PubMed ID: 21439690
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agents.
Li WT; Hwang DR; Chen CP; Shen CW; Huang CL; Chen TW; Lin CH; Chang YL; Chang YY; Lo YK; Tseng HY; Lin CC; Song JS; Chen HC; Chen SJ; Wu SH; Chen CT
J Med Chem; 2003 Apr; 46(9):1706-15. PubMed ID: 12699388
[TBL] [Abstract][Full Text] [Related]
16. 2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazoles: search for anticancer agents.
Noolvi MN; Patel HM; Kamboj S; Kaur A; Mann V
Eur J Med Chem; 2012 Oct; 56():56-69. PubMed ID: 22960694
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer activity of Indolin-2-one derivatives bearing the 4-thiazolidinone moiety.
Wang S; Zhao Y; Zhu W; Liu Y; Guo K; Gong P
Arch Pharm (Weinheim); 2012 Jan; 345(1):73-80. PubMed ID: 21932254
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 1-(4'-Indolyl and 6'-Quinolinyl) indoles as a new class of potent anticancer agents.
Lai MJ; Chang JY; Lee HY; Kuo CC; Lin MH; Hsieh HP; Chang CY; Wu JS; Wu SY; Shey KS; Liou JP
Eur J Med Chem; 2011 Sep; 46(9):3623-9. PubMed ID: 21641700
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new chiral 2,5-disubstituted 1,3,4-thiadiazoles possessing gamma-butenolide moiety and preliminary evaluation of in vitro anticancer activity.
Wei MX; Feng L; Li XQ; Zhou XZ; Shao ZH
Eur J Med Chem; 2009 Aug; 44(8):3340-4. PubMed ID: 19371980
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazoles.
Revelant G; Gadais C; Mathieu V; Kirsch G; Hesse S
Bioorg Med Chem Lett; 2014 Jun; 24(12):2724-7. PubMed ID: 24815511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
